Titre : | Dropout from 12-step self-help groups : prevalence, predictors, and counteracting treatment influences |
Titre traduit : | (Abandon d'un groupe d'entraide en 12 étapes : prévalence, prédicteurs et influences sur le traitement) |
Auteurs : | J. F. KELLY ; R. MOOS |
Type de document : | Périodique |
Année de publication : | 2003 |
Format : | 241-250 / graph. ; tabl. |
Note générale : |
Journal of Substance Abuse Treatment, 2003, 24, (3), 241-250 |
Langues: | Anglais |
Discipline : | TRA (Traitement et prise en charge / Treatment and care) |
Mots-clés : |
Thésaurus mots-clés ENTRAIDE ; OBSERVANCE DU TRAITEMENT ; FACTEUR DE VULNERABILITE ; EPIDEMIOLOGIE DESCRIPTIVEThésaurus géographique ETATS-UNIS |
Résumé : |
ENGLISH : Attendance at 12-step self-help groups is frequently recommended as an adjunct to professional substance use disorder (SUD) treatment, yet patient dropout from these groups is common. This study assessed the prevalence, predictors, and treatment-related factors affecting dropout in the first year following treatment for 2,778 male patients. Of these, 91% (2,518) were identified as having attended 12-step groups either in the 90 days prior to, or during, treatment. At 1-year followup 40% had dropped out. A number of baseline factors predicted dropout. Importantly, patients who initiated 12-step behaviors during treatment were less likely to drop out. Further findings suggest patients at highest risk for dropout may be at lower risk if treated in a more supportive environment. Clinicians may decrease the likelihood of dropout directly, by screening for risk factors and focusing facilitation efforts accordingly, and indirectly, by increasing the supportiveness of the treatment environment, and facilitating 12-step involvement during treatment. (Editor's abstract.) |
Note de contenu : | graph. ; tabl. |
Domaine : | Plusieurs produits / Several products |
Refs biblio. : | 39 |
Affiliation : |
Ctr. Healthcare Evaluation, Veterans Affairs Palo Alto Healthcare System Stanford Univ. Sch. Med., 795 Willow Rd, Menlo Park, CA 94025. E-mail : john.kelly4med.va.gov Etats-Unis. United States. |
Numéro Toxibase : | 404334 |
Centre Emetteur : | 04 CIRDD-51 |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil